Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats

Carley, 2002, Functional role for cannabinoids in respiratory stability during sleep, Sleep, 25, 391, 10.1093/sleep/25.4.388

Goonawardena, 2015, Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459, Behav Pharmacol, 26, 289, 10.1097/FBP.0000000000000108

Schierenbeck, 2008, Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana, Sleep Med Rev, 12, 381, 10.1016/j.smrv.2007.12.004

Calik, 2014, Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats, PLoS One, 9, e111412, 10.1371/journal.pone.0111412

Calik, 2014, Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat, Respir Physiol Neurobiol, 190, 20, 10.1016/j.resp.2013.10.001

Silvani, 2014, Cardiorespiratory anomalies in mice lacking CB1 cannabinoid receptors, PLoS One, 9, e100536, 10.1371/journal.pone.0100536

Carley, 2008, Pharmacology of vagal afferent influences on disordered breathing during sleep, Respir Physiol Neurobiol, 164, 197, 10.1016/j.resp.2008.06.021

Peppard, 2013, Increased prevalence of sleep-disordered breathing in adults, Am J Epidemiol, 177, 1006, 10.1093/aje/kws342

Mendelson, 1988, Periodic cessation of respiratory effort during sleep in adult rats, Physiol Behav, 43, 229, 10.1016/0031-9384(88)90243-0

Stephenson, 2006, The effect of time of day on apnoea index in the sleeping rat, Respir Physiol Neurobiol, 154, 351, 10.1016/j.resp.2006.02.007

Wang, 2008, Expression of TASK-1 in brainstem and the occurrence of central sleep apnea in rats, Respir Physiol Neurobiol, 161, 23, 10.1016/j.resp.2007.11.008

Rukhadze, 2014, Lingual muscle activity across sleep-wake States in rats with surgically altered upper airway, Front Neurol, 5, 61, 10.3389/fneur.2014.00061

Carley, 1996, Sleep apnea in normal and REM sleep-deprived normotensive Wistar-Kyoto and spontaneously hypertensive (SHR) rats, Physiol Behav, 59, 827, 10.1016/0031-9384(95)02205-8

Prasad, 2013, Proof of concept trial of dronabinol in obstructive sleep apnea, Front Psychiatry, 4, 1, 10.3389/fpsyt.2013.00001

Issa, 1992, Effect of clonidine in obstructive sleep apnea, Am Rev Respir Dis, 145, 435, 10.1164/ajrccm/145.2_Pt_1.435

Barann, 2002, Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site, Br J Pharmacol, 137, 589, 10.1038/sj.bjp.0704829

Fan, 1995, Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons, J Neurophysiol, 73, 907, 10.1152/jn.1995.73.2.907

Yang, 2010, The effect of Δ9-tetrahydrocannabinol on 5-HT3 receptors depends on the current density, Neuroscience, 171, 40, 10.1016/j.neuroscience.2010.08.044

Davis, 2013, Rodent models of sleep apnea, Respir Physiol Neurobiol, 188, 355, 10.1016/j.resp.2013.05.022

Topchiy, 2014, Acute exacerbation of sleep apnea by hyperoxia impairs cognitive flexibility in Brown-Norway rats, Sleep, 37, 1851, 10.5665/sleep.4184

Ramirez, 2013, Central and peripheral factors contributing to obstructive sleep apneas, Respir Physiol Neurobiol, 189, 344, 10.1016/j.resp.2013.06.004

Saponjic, 2007, Monoaminergic system lesions increase post-sigh respiratory pattern disturbance during sleep in rats, Physiol Behav, 90, 1, 10.1016/j.physbeh.2006.08.019

Dempsey, 2010, Pathophysiology of sleep apnea, Physiol Rev, 90, 47, 10.1152/physrev.00043.2008

Sands, 2014, Enhanced upper-airway muscle responsiveness is a distinct feature of overweight/obese individuals without sleep apnea, Am J Respir Crit Care Med, 190, 930, 10.1164/rccm.201404-0783OC

Radulovacki, 1998, Serotonin 5-HT3-receptor antagonist GR 38032F suppresses sleep apneas in rats, Sleep, 21, 131, 10.1093/sleep/21.2.131

Prasad, 2010, Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome, Sleep, 33, 982, 10.1093/sleep/33.7.982

Watanabe, 2000, Evaluation of absorbability of poorly water-soluble drugs: validity of the use of additives, Biol Pharm Bull, 23, 838, 10.1248/bpb.23.838

Brayton, 1986, Dimethyl sulfoxide (DMSO): a review, Cornell Vet, 76, 61

Elzinga, 1989, The effect of dimethyl sulfoxide on the absorption of cyclosporine in rats, Transplantation, 47, 394, 10.1097/00007890-198902000-00043

Denko, 1967, Distribution of dimethyl sulfoxide-35S in the rat, Ann N Y Acad Sci, 141, 77, 10.1111/j.1749-6632.1967.tb34868.x

Hucker, 1966, Absorption, distribution and metabolism of dimethylsulfoxide in the rat, rabbit and guinea pig, J Pharmacol Exp Ther, 154, 176

Broadwell, 1982, Morphologic effect of dimethyl sulfoxide on the blood-brain barrier, Science, 217, 164, 10.1126/science.7089551

Donoso, 1977, Dimethylsulfoxide action on fast axoplasmic transport and ultrastructure of vagal axons, Brain Res, 120, 287, 10.1016/0006-8993(77)90907-6

Sams, 1966, Effect of dimethylsulfoxide on isolated-innervated skeletal, smooth, and cardiac muscle, Proc Soc Exp Biol Med, 122, 103, 10.3181/00379727-122-31063

Fossum, 2008, Microinjection of the vehicle dimethyl sulfoxide (DMSO) into the periaqueductal gray modulates morphine antinociception, Brain Res, 1204, 53, 10.1016/j.brainres.2008.02.022

Cavas, 2005, Behavioural effects of dimethyl sulfoxide (DMSO): changes in sleep architecture in rats, Toxicol Lett, 157, 221, 10.1016/j.toxlet.2005.02.003

Navarro, 2003, Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound, Neuroscience, 120, 855, 10.1016/S0306-4522(03)00339-7

Silvani, 2014, Multiple sleep alterations in mice lacking cannabinoid type 1 receptors, PLoS One, 9, e89432, 10.1371/journal.pone.0089432

Pava, 2014, Endocannabinoid modulation of cortical up-states and NREM sleep, PLoS One, 9, e88672, 10.1371/journal.pone.0088672

Demuth, 2006, Cannabinoid signalling, Life Sci, 78, 549, 10.1016/j.lfs.2005.05.055

Schwartz, 2015, The Neurobiology of Sleep and Wakefulness, Psychiatr Clin North Am, 38, 615, 10.1016/j.psc.2015.07.002

Gates, 2014, The effects of cannabinoid administration on sleep: a systematic review of human studies, Sleep Med Rev, 18, 477, 10.1016/j.smrv.2014.02.005

Haji, 2000, Neuropharmacology of control of respiratory rhythm and pattern in mature mammals, Pharmacol Ther, 86, 277, 10.1016/S0163-7258(00)00059-0

Mazzone, 2002, Central nervous system control of the airways: pharmacological implications, Curr Opin Pharmacol, 2, 220, 10.1016/S1471-4892(02)00151-0

Rohof, 2012, Localization of mGluR5, GABAB, GABAA, and cannabinoid receptors on the vago-vagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study, Neurogastroenterol Motil, 24, 383, 10.1111/j.1365-2982.2011.01868.x

Mukhtarov, 2005, Dual Ca2+ modulation of glycinergic synaptic currents in rodent hypoglossal motoneurones, J Physiol, 569, 817, 10.1113/jphysiol.2005.094862

Calik, 2016, Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats, J Negat Results Biomed, 15, 8, 10.1186/s12952-016-0052-1

Van Sickle, 2005, Identification and functional characterization of brainstem cannabinoid CB2 receptors, Science, 310, 329, 10.1126/science.1115740

Tree, 2010, Anandamide centrally depresses the respiratory rhythm generator of neonatal mice, Neuroscience, 170, 1098, 10.1016/j.neuroscience.2010.08.045

Pertwee, 2005, Pharmacological actions of cannabinoids, Handb Exp Pharmacol, 168, 1, 10.1007/3-540-26573-2_1

Baur, 2012, The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors, Br J Pharmacol, 165, 2479, 10.1111/j.1476-5381.2011.01405.x

Pertwee, 2008, The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin, Br J Pharmacol, 153, 199, 10.1038/sj.bjp.0707442

Radulovacki, 2001, Riluzole suppresses post-sigh, but not spontaneous apnoeas during sleep in rats, J Pharm Pharmacol, 53, 1555, 10.1211/0022357011777936

Guyenet, 2010, Retrotrapezoid nucleus and parafacial respiratory group, Respir Physiol Neurobiol, 173, 244, 10.1016/j.resp.2010.02.005

Silva, 2016, Neuroanatomical and physiological evidence that the retrotrapezoid nucleus/parafacial region regulates expiration in adult rats, Respir Physiol Neurobiol, 227, 9, 10.1016/j.resp.2016.02.005

Li, 2016, The peptidergic control circuit for sighing, Nature, 530, 293, 10.1038/nature16964

Yamauchi, 2008, Post-sigh breathing behavior and spontaneous pauses in the C57BL/6J (B6) mouse, Respir Physiol Neurobiol, 162, 117, 10.1016/j.resp.2008.05.003

Nakamura, 2003, Sleep apnea and effect of chemostimulation on breathing instability in mice, J Appl Physiol (1985), 94, 525, 10.1152/japplphysiol.00226.2002

Buonamici, 1982, Effects of acute delta 9-THC administration on EEG and EEG power spectra in the rat, Neuropharmacology, 21, 825, 10.1016/0028-3908(82)90071-5

Carley, 1999, Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat, Am J Respir Crit Care Med, 160, 1824, 10.1164/ajrccm.160.6.9902090

Carley, 1996, Effects of sleep fragmentation and clonidine administration on apnea in the rat, Res Commun Psychol Psychiatr Behav, 20, 95

Horner, 1995, Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs, J Appl Physiol (1985), 79, 151, 10.1152/jappl.1995.79.1.151

Klein, 2011, Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats, Psychopharmacology (Berl), 218, 443, 10.1007/s00213-011-2342-0

AbbVie Inc

Rock, 2015, Effect of combined doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague-Dawley) models of conditioned gaping, Psychopharmacology (Berl), 232, 4445, 10.1007/s00213-015-4080-1

Boctor, 2007, The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding, Eur J Pharmacol, 571, 39, 10.1016/j.ejphar.2007.06.004

Chennaoui, 2015, Sleep and exercise: a reciprocal issue?, Sleep Med Rev, 20, 59, 10.1016/j.smrv.2014.06.008

Sériès, 1998, Upper airway mucosa temperature in obstructive sleep apnoea/hypopnoea syndrome, nonapnoeic snorers and nonsnorers, Eur Respir J, 12, 193, 10.1183/09031936.98.12010193